Ginkgo Bioworks, Certis Biologicals Buy AgBiome Assets
Boston-based Ginkgo Bioworks, which is building a platform for cell programming and biosecurity, and biological pesticides provider Certis Biologicals, Columbia, Md., have separately announced that they have bought assets from AgBiome, Research Triangle Park, N.C.
Ginkgo on April 11 said it has acquired AgBiome’s platform assets, including over 115,000 fully sequenced and isolated strains, over 500 million unique gene sequences, and relevant functional data and metadata, as well as AgBiome’s development pipeline.
“We are so excited to bring AgBiome’s incredible strain and metagenomic collection into Ginkgo,” said Michael Miille, Gingko Fellow. “This is a world class asset that will significantly expand our capabilities and can directly benefit Ginkgo’s customers in the ag biologicals space. In addition to the platform assets and capabilities, the product concepts pipeline that has been validated by AgBiome to date provides an exciting opportunity to give customers a head-start in their product development efforts.”
“These assets represent a massive, ground-breaking investment into exploring and characterizing microbial diversity for human benefit, and we can’t think of a better home for them than the Ginkgo platform,” said Laura Potter, Agbiome Chief Science Officer.
Ginkgo said the assets will be integrated into Ginkgo Ag Biologicals Services, established with the acquisition of a Bayer agricultural biologicals R&D facility in 2022, and will expand Ginkgo’s proprietary unified metagenomics database. It said combined, this creates one of the deepest and most advanced ag biological discovery and development platforms as well as a rich resource for the development of AI models for biological R&D.
Founded in 2012, AgBiome has worked to generate an extensive collection of biological products and technologies through its Genesis Discovery Platform, including agricultural products, bioactive ingredients, and gene editing tools.
AgBiome has successfully commercialized multiple biological products, including the Howler® and Theia® fungicide product lines, which, along with other “multiple assets,” are being bought by Certis, a wholly-owned subsidiary of Mitsui & Co, according to March 18 announcements by Certis and AgBiome. The two fungicides will be added to the Certis portfolio of more than 40 products that control pests, diseases, and weeds.
“Howler and Theia complement our existing portfolio of biofungicides, including Double Nickel® and our newest product for large-acre crops, Convergence®,” said Chris Judd, Vice President, North America, Certis Biologicals. “These products will constitute a fungicide portfolio that can provide unmatched control for all growers, from specialty and high-value crops to large-acre commodity crops.”
“AgBiome’s products, Howler and Theia fungicides, are the most effective biological fungicides with unique modes of action and efficacy similar to synthetic chemicals but with substantial environmental benefits,” said Scott Rabe, AgBiome Head of Product Development. “We are delighted that a company like Certis Biologicals, with a deep commitment to these products, will steward their future growth and development. More growers than ever will be able to see firsthand the benefits of these products.”
While AgBiome has received multiple major grants from the Bill and Melinda Gates Foundation and other investors, in October 2023 it said it was having trouble raising capital and was developing plans to lay off potentially all of its employees (GM Oct. 27, 2023). AgBiome had not responded to inquiries at press time.